JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
Patterson-UTI
PTEN
$4.31B
| $15.4M | ﹤0.01% |
1,544,353
+13,386
| +0.9% | +$113K |
2013 Q2
32 quarters
|
|
|
B
2002
DELISTED
Barnes Group Inc.
B
| $15.3M | ﹤0.01% |
299,436
-31,891
| -10% | -$1.65M |
2013 Q2
32 quarters
|
|
|
RDFN
2003
DELISTED
Redfin
RDFN
| $15.3M | ﹤0.01% |
241,992
-127,226
| -34% | -$7.78M |
2017 Q3
15 quarters
|
|
2004
Chemours
CC
$2.03B
| $15.3M | ﹤0.01% |
440,116
-84,451
| -16% | -$2.8M |
2015 Q3
23 quarters
|
|
2005
NRG Energy
NRG
$20.4B
| $15.3M | ﹤0.01% |
379,404
-979,082
| -72% | -$35.5M |
2013 Q2
32 quarters
|
|
2006
Valley National Bancorp
VLY
$7B
| $15.3M | ﹤0.01% |
1,136,803
-612,832
| -35% | -$8.56M |
2013 Q2
32 quarters
|
|
2007
Hormel Foods
HRL
$11B
| $15.2M | ﹤0.01% |
318,711
-262,388
| -45% | -$12.5M |
2013 Q2
32 quarters
|
|
2008
CALL
Amgen
AMGN
$220B
| $15.2M | ﹤0.01% |
62,400
+23,600
| +61% | +$5.81M |
2014 Q3
27 quarters
|
|
2009
Ternium
TX
$10.9B
| $15.2M | ﹤0.01% |
394,913
+60,186
| +18% | +$2.3M |
2015 Q4
22 quarters
|
|
|
VMW
2010
DELISTED
VMware, Inc
VMW
| $15.1M | ﹤0.01% |
94,572
-15,299
| -14% | -$2.45M |
2013 Q2
32 quarters
|
|
2011
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.73B
| $15.1M | ﹤0.01% |
396,558
-31,100
| -7% | -$1.17M |
2014 Q1
29 quarters
|
|
2012
Murphy Oil
MUR
$5.37B
| $15M | ﹤0.01% |
645,426
+226,952
| +54% | +$4.63M |
2013 Q2
32 quarters
|
|
2013
Ashland
ASH
$3.14B
| $15M | ﹤0.01% |
171,605
-756
| -0.4% | -$68.1K |
2013 Q2
32 quarters
|
|
2014
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.76B
| $15M | ﹤0.01% |
367,597
+15,286
| +4% | +$618K |
2017 Q2
16 quarters
|
|
2015
Plains GP Holdings
PAGP
$5.13B
| $14.9M | ﹤0.01% |
1,249,766
+507,539
| +68% | +$5.41M |
2013 Q4
30 quarters
|
|
2016
TIM SA
TIMB
$8.29B
| $14.9M | ﹤0.01% |
1,294,136
+97,914
| +8% | +$1.14M |
2017 Q3
15 quarters
|
|
|
NXGN
2017
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $14.9M | ﹤0.01% |
898,040
+395,354
| +79% | +$7.08M |
2016 Q4
18 quarters
|
|
2018
PUT
ARK Innovation ETF
ARKK
$9.57B
| $14.9M | ﹤0.01% |
113,900
-812,400
| -88% | -$94.7M |
2021 Q1
1 quarter
|
|
2019
Lumentum
LITE
$93.8B
| $14.9M | ﹤0.01% |
181,186
-22,991
| -11% | -$1.93M |
2015 Q3
23 quarters
|
|
|
LCI
2020
DELISTED
Lannett Company, Inc.
LCI
| $14.8M | ﹤0.01% |
794,833
-63,880
| -7% | -$1.23M |
2015 Q4
22 quarters
|
|
|
AYX
2021
DELISTED
Alteryx Inc
AYX
| $14.8M | ﹤0.01% |
172,263
-833,843
| -83% | -$68.2M |
2017 Q1
17 quarters
|
|
2022
Vodafone
VOD
$37.9B
| $14.8M | ﹤0.01% |
864,958
+17,975
| +2% | +$337K |
2013 Q2
32 quarters
|
|
2023
Crane NXT
CXT
$2.77B
| $14.8M | ﹤0.01% |
461,498
+24,057
| +5% | +$785K |
2013 Q2
32 quarters
|
|
|
EGRX
2024
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $14.8M | ﹤0.01% |
345,475
+276,753
| +403% | +$11.4M |
2017 Q3
15 quarters
|
|
|
SAFM
2025
DELISTED
Sanderson Farms Inc
SAFM
| $14.8M | ﹤0.01% |
78,621
+9,939
| +14% | +$1.67M |
2013 Q2
32 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.